Gilead Sciences Inc (NAS:GILD)
$ 67.9 0.18 (0.27%) Market Cap: 84.59 Bil Enterprise Value: 104.85 Bil PE Ratio: 188.61 PB Ratio: 4.83 GF Score: 74/100

Gilead Sciences Inc at Jefferies Healthcare Conference Transcript

Jun 05, 2019 / 03:30PM GMT
Release Date Price: $64.44 (+0.19%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

All right. We're going to go ahead and get started because I want all of 30 minutes here for my discussion with Mr. O'Day. But as you know, I'm really excited and happy to have the new Chairman and CEO of Gilead Sciences up here with me, Mr. Daniel O'Day. Great to have you here with us on your first investor coming-out session to meet the -- to meet all of Wall Street.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Now of course, you know most people on Wall Street from your time at Roche, but now that you've had some time to settle in at Gilead, maybe just talk to us about how it's been. What have you been focused on at Gilead in your time there? And obviously, what are you most focused on at Gilead over the foreseeable future? And we'll get in some of the details of that.

Daniel O;Day
Gilead Sciences, Inc. - Chairman & CEO

' -

Yes, sure. So first of all, Michael, thank

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot